Exclusive

Publication

Byline

Location

US Patent Issued to GEn1E Lifesciences on April 7 for "Modulators of extracellular signal-regulated kinase" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,243, issued on April 7, was assigned to GEn1E Lifesciences Inc. (Palo Alto, Calif.). "Modulators of extracellular signal-regulated kinase" ... Read More


US Patent Issued to Jnana Therapeutics on April 7 for "Small molecule inhibitors of mammalian SLC6A19 function" (New Hampshire, Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,244, issued on April 7, was assigned to Jnana Therapeutics Inc. (Boston). "Small molecule inhibitors of mammalian SLC6A19 function" was inv... Read More


US Patent Issued to CELYN THERAPEUTICS on April 7 for "Inhibitors of MET kinase" (California, Florida Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,245, issued on April 7, was assigned to CELYN THERAPEUTICS INC. (San Diego). "Inhibitors of MET kinase" was invented by Xiaohu S. Ouyang (R... Read More


US Patent Issued to BETA PHARMA on April 7 for "Crystalline and amorphous forms of N-(5-((4-ethylpiperazin-1-yl)methyl)pyridine-2-yl)-5-fluoro-4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-amine and its salts, and preparation methods and therapeutic uses thereof" (Pennsylvania, Wisconsin, New Jersey Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,246, issued on April 7, was assigned to BETA PHARMA INC. (Wilmington, Del.). "Crystalline and amorphous forms of N-(5-((4-ethylpiperazin-1-... Read More


US Patent Issued to Bayer on April 7 for "Substituted pyrazolo piperidine carboxylic acids" (German Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,247, issued on April 7, was assigned to Bayer AG (Leverkusen, Germany). "Substituted pyrazolo piperidine carboxylic acids" was invented by ... Read More


US Patent Issued to Merck Sharp & Dohme on April 7 for "PRMT5 inhibitors" (Canadian, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,248, issued on April 7, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "PRMT5 inhibitors" was invented by Michelle Machacek (Belmo... Read More


US Patent Issued to MINDRANK AI on April 7 for "Aryl ether-substituted heterocyclic compounds as glpir agonists" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,249, issued on April 7, was assigned to MINDRANK AI LTD. (Hangzhou, China). "Aryl ether-substituted heterocyclic compounds as glpir agonist... Read More


US Patent Issued to ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY on April 7 for "Substituted pyrimidine compounds as multifunctional radical quenchers and their uses" (American, French Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,250, issued on April 7, was assigned to ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (Scottsdale, Ariz.). "Substituted py... Read More


US Patent Issued to GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION on April 7 for "Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics" (Georgia, North Carolina Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,251, issued on April 7, was assigned to GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC. (Atlanta). "Amidines and amidine analogs for the ... Read More


US Patent Issued to DISARM THERAPEUTICS on April 7 for "Inhibitors of SARM1" (British, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,252, issued on April 7, was assigned to DISARM THERAPEUTICS INC. (Indianapolis). "Inhibitors of SARM1" was invented by Robert Owen Hughes (... Read More